3D QSAR studies for a series of Trypanosoma cruzi dehydrogenase inhibitors (2019)
Source: Anais eletrônicos. Conference titles: Brazilian Symposium on Medicinal Chemistry - BrazMedChem. Unidade: IFSC
Subjects: DOENÇA DE CHAGAS, PLANEJAMENTO DE FÁRMACOS, QUÍMICA MÉDICA, TRYPANOSOMA CRUZI, CRISTALOGRAFIA
ABNT
FERREIRA, Leonardo Luiz Gomes et al. 3D QSAR studies for a series of Trypanosoma cruzi dehydrogenase inhibitors. 2019, Anais.. Campinas: Galoá, 2019. Disponível em: https://proceedings.science/p/107096. Acesso em: 17 maio 2024.APA
Ferreira, L. L. G., Jesus, G. C., Ribeiro, T. S., & Andricopulo, A. D. (2019). 3D QSAR studies for a series of Trypanosoma cruzi dehydrogenase inhibitors. In Anais eletrônicos. Campinas: Galoá. Recuperado de https://proceedings.science/p/107096NLM
Ferreira LLG, Jesus GC, Ribeiro TS, Andricopulo AD. 3D QSAR studies for a series of Trypanosoma cruzi dehydrogenase inhibitors [Internet]. Anais eletrônicos. 2019 ;[citado 2024 maio 17 ] Available from: https://proceedings.science/p/107096Vancouver
Ferreira LLG, Jesus GC, Ribeiro TS, Andricopulo AD. 3D QSAR studies for a series of Trypanosoma cruzi dehydrogenase inhibitors [Internet]. Anais eletrônicos. 2019 ;[citado 2024 maio 17 ] Available from: https://proceedings.science/p/107096